Copyright
©The Author(s) 2018.
World J Gastroenterol. May 28, 2018; 24(20): 2152-2162
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2152
Published online May 28, 2018. doi: 10.3748/wjg.v24.i20.2152
Table 2 Comparison of published selection criteria for liver transplantation in neuroendocrine liver metastases, and cirrhosis with hepatocellular carcinoma
Criteria and context | Parameters |
Milan NET criteria[42] Neuroendocrine liver metastases | Age < 60 G1/G2 tumour grade Primary tumour drained by the portal venous system Metastatic involvement limited to the liver Hepatic tumour burden not > 50% Six months of no tumour progression |
Milan criteria[62] HCC and cirrhosis | Single tumour ≤ 5 cm Or, ≤ 3 tumours each ≤ 3 cm in size No macrovascular invasion |
UCSF criteria[63] HCC and cirrhosis | Single lesion ≤ 6.5 cm Or, 2-3 lesions ≤ 4.5 cm each, with total tumour diameter ≤ 8 cm No macrovascular invasion |
Navarro criteria[64] HCC and cirrhosis | Single lesion ≤ 6 cm Or, 2-3 lesions ≤ 5 cm each No macrovascular invasion |
Valencia criteria[65] HCC and cirrhosis | 1-3 lesions ≤ 5 cm each, total tumour dimeter ≤ 10 cm No macrovascular invasion |
‘Up-to-7’ criteria[66] HCC | Number of tumours + size of tumours (in cm) ≤ 7 No microvascular invasion |
- Citation: Clift AK, Frilling A. Liver transplantation and multivisceral transplantation in the management of patients with advanced neuroendocrine tumours. World J Gastroenterol 2018; 24(20): 2152-2162
- URL: https://www.wjgnet.com/1007-9327/full/v24/i20/2152.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i20.2152